Skip Navigation

Cardiovascular Research 2005 67(3):367-378; doi:10.1016/j.cardiores.2005.03.005
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Meregalli, P. G.
Right arrow Articles by Tan, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meregalli, P. G.
Right arrow Articles by Tan, H. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, European Society of Cardiology

Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder, or more?

Paola G. Meregalli, Arthur A.M. Wilde and Hanno L. Tan*

Department of Cardiology, Room M0-105, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands

* Corresponding author. Tel.: +31 20 5663265; fax: +31 20 6975458. Email address: h.l.tan{at}amc.uva.nl

After its recognition as a distinct clinical entity, Brugada syndrome is increasingly recognized worldwide as an important cause of sudden cardiac death. Brugada syndrome exhibits autosomal dominant inheritance with SCN5A, which encodes the cardiac sodium channel, as the only gene with a proven involvement in 20–30% of patients. Its signature feature is ST segment elevation in right precordial ECG leads and predisposition to malignant ventricular tachyarrhythmias. The pathophysiological mechanism of ST elevation and ventricular tachyarrhythmia, two phenomena strongly related, is controversial. Here, we review clinical and experimental studies as they provide evidence to support or disprove the two hypotheses on the mechanism of Brugada syndrome that currently receive the widest support: (1) nonuniform abbreviation of right ventricular epicardial action potentials ("repolarization disorder"), (2) conduction delay in the right ventricular outflow tract ("depolarization disorder"). We also propose a schematic representation of the depolarization disorder hypothesis. Moreover, we review recent evidence to suggest that other derangements may also contribute to the pathophysiology of Brugada syndrome, in particular, right ventricular structural derangements.

In reviewing these studies, we conclude that, similar to most diseases, it is likely that Brugada syndrome is not fully explained by one single mechanism. Rather than adhering to the notion that Brugada syndrome is a monofactorial disease, we should aim for clarification of the contribution of various pathophysiological mechanisms in individual Brugada syndrome patients and tailor therapy considering each of these mechanisms.

KEYWORDS Arrhythmia; Sudden death; Ion channels; Conduction (block)

Time for primary review 20 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
S. Petitprez, T. Jespersen, E. Pruvot, D. I. Keller, C. Corbaz, J. Schlapfer, H. Abriel, and J. P. Kucera
Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome
Cardiovasc Res, June 1, 2008; 78(3): 494 - 504.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Nagase, K. F. Kusano, H. Morita, N. Nishii, K. Banba, A. Watanabe, S. Hiramatsu, K. Nakamura, S. Sakuragi, and T. Ohe
Longer Repolarization in the Epicardium at the Right Ventricular Outflow Tract Causes Type 1 Electrocardiogram in Patients With Brugada Syndrome
J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1154 - 1161.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Casini, H. L. Tan, Z. A. Bhuiyan, C. R. Bezzina, P. Barnett, E. Cerbai, A. Mugelli, A. A.M. Wilde, and M. W. Veldkamp
Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation
Cardiovasc Res, December 1, 2007; 76(3): 418 - 429.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
K. H.W.J. Ten Tusscher and A. V. Panfilov
Influence of diffuse fibrosis on wave propagation in human ventricular tissue
Europace, November 1, 2007; 9(suppl_6): vi38 - vi45.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Lampert, S. D. Dib-Hajj, L. Tyrrell, and S. G. Waxman
Size Matters: Erythromelalgia Mutation S241T in Nav1.7 Alters Channel Gating
J. Biol. Chem., November 24, 2006; 281(47): 36029 - 36035.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. R. Bezzina, W. Shimizu, P. Yang, T. T. Koopmann, M. W.T. Tanck, Y. Miyamoto, S. Kamakura, D. M. Roden, and A. A.M. Wilde
Common Sodium Channel Promoter Haplotype in Asian Subjects Underlies Variability in Cardiac Conduction
Circulation, January 24, 2006; 113(3): 338 - 344.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
A. A M Wilde and C. R Bezzina
Genetics of cardiac arrhythmias
Heart, October 1, 2005; 91(10): 1352 - 1358.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
C. R. Bezzina, A. A.M. Wilde, and D. M. Roden
The molecular genetics of arrhythmias
Cardiovasc Res, August 15, 2005; 67(3): 343 - 346.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.